Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Recruiting × Advanced Cancer × Clear all

Phase

Phase 1 8 Phase NA 6 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 22 Prostatic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Breast Neoplasms 12 Pancreatic Neoplasms 11 Colorectal Neoplasms 11 Stomach Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Leukemia, Myeloid, Acute 9 Hematologic Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Hepatocellular 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Head and Neck Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Recurrence 7 Ovarian Neoplasms 7 Myasthenia Gravis 7 Melanoma 7 Uterine Cervical Neoplasms 6 Rectal Neoplasms 6 Neoplasms by Site 6 Neoplasms by Histologic Type 6 Lymphoma 6 Leukemia 6 Urinary Bladder Neoplasms 5 Neoplasms, Plasma Cell 5 Infections 5 Multiple Myeloma 4

Interventions

Psychotherapy 1 Niacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡